Skip to main content
# Title Department Research Member Research Year
121 Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: a possible prognostic marker
Department of Clinical Pathology Dr. Asmaa Mohamed Zahran Omar 2021
122 Risk of drug resistance and repeated infection with Klebsiella pneumoniae and Escherichia coli in intensive care unit cancer patients Department of Pediatric Oncology Dr. Ahmed Mohammed Morsy Hassan 2021
123 Two-be SPECT/CT versus planar bone scintigraphy: Prospective comparison of reproducibility and diagnostic performance Department of Radiotherapy and Nuclear medicine Dr. Yasser Gaber Ali Abdelhafez 2021
124 Higher CD19+ CD25+ Bregs are independently associated with better graft function in renal transplant recipients Department of Clinical Pathology Eman Hosny Mohammed Ibrahim 2021
125 Assessment of the clinical value of red cell distribution width in patients with de novo hepatocellular carcinoma following HCV clearance with the direct-acting antiviral agents Department of Medical Oncology Dr. Hanaan Ahmed Mohammed Ahmed 2021
126 Role of Metastatic Colon Cancer Topography in Pathological and Molecular Variability : A Retrospective Study Department of Medical Oncology Matta Gerges Mounir Meshreky 2021
127 Role of Metastatic Colon Cancer Topography in Pathological and Molecular Variability : A Retrospective Study Department of Medical Oncology Dr. Mayada Fawzy Sedik Farghaly 2021
128 Increase in polymorphonuclear myeloid‑derived suppressor cells and regulatory T‑cells in children with B‑cell acute lymphoblastic leukemia Department of Pediatric Oncology Dr. Amira Mahmoud Mohammed Osman 2021
129 The utility of Multi-Detector Computed Tomography criteria after neoadjuvant therapy in Borderline Resectable Pancreatic cancer: Prospective, bi-institutional study Department of Radiology Dr. Shimaa abdulla Ahmed Mohammed Hassan 2021
130 Role of post-therapy 99mTc-MIBI single-photon emission computed tomography/computed tomography scan in predicting survival in patients with high-grade glioma Department of Radiotherapy and Nuclear medicine Dr. Esraa Roshdy Hassan Mohamed 2021